Literature DB >> 23302151

Estimation of HIV incidence using multiple biomarkers.

Ron Brookmeyer1, Jacob Konikoff, Oliver Laeyendecker, Susan H Eshleman.   

Abstract

The incidence of human immunodeficiency virus (HIV) is the rate at which new HIV infections occur in populations. The development of accurate, practical, and cost-effective approaches to estimation of HIV incidence is a priority among researchers in HIV surveillance because of limitations with existing methods. In this paper, we develop methods for estimating HIV incidence rates using multiple biomarkers in biological samples collected from a cross-sectional survey. An advantage of the method is that it does not require longitudinal follow-up of individuals. We use assays for BED, avidity, viral load, and CD4 cell count data from clade B samples collected in several US epidemiologic cohorts between 1987 and 2010. Considering issues of accuracy, cost, and implementation, we identify optimal multiassay algorithms for estimating incidence. We find that the multiple-biomarker approach to cross-sectional HIV incidence estimation corrects the significant deficiencies of currently available approaches and is a potentially powerful and practical tool for HIV surveillance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23302151      PMCID: PMC3626051          DOI: 10.1093/aje/kws436

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  40 in total

1.  Forward and backward recurrence times and length biased sampling: age specific models.

Authors:  Marvin Zelen
Journal:  Lifetime Data Anal       Date:  2004-12       Impact factor: 1.588

2.  UNAIDS Reference Group on estimates, modelling and projections--statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-01-27

3.  Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay.

Authors:  John W Hargrove; Jean H Humphrey; Kuda Mutasa; Bharat S Parekh; J Steve McDougal; Robert Ntozini; Henry Chidawanyika; Lawrence H Moulton; Brian Ward; Kusum Nathoo; Peter J Iliff; Ekkehard Kopp
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

4.  A Simplified Formula for Inferring HIV Incidence from Cross-Sectional Surveys Using a Test for Recent Infection.

Authors:  Alex Welte; Thomas A McWalter; Till Bärnighausen
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

5.  Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.

Authors:  R D Moore
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

6.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

7.  Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.

Authors:  J Steven McDougal; Bharat S Parekh; Michael L Peterson; Bernard M Branson; Trudy Dobbs; Marta Ackers; Marc Gurwith
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

8.  Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data.

Authors:  Stephen R Cole; Haitao Chu; Ron Brookmeyer
Journal:  Am J Epidemiol       Date:  2006-10-20       Impact factor: 4.897

9.  Risk factors for recent HIV infection in Uganda.

Authors:  Jonathan Mermin; Joshua Musinguzi; Alex Opio; Wilford Kirungi; John Paul Ekwaru; Wolfgang Hladik; Frank Kaharuza; Robert Downing; Rebecca Bunnell
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

10.  Estimating incidence from prevalence in generalised HIV epidemics: methods and validation.

Authors:  Timothy B Hallett; Basia Zaba; Jim Todd; Ben Lopman; Wambura Mwita; Sam Biraro; Simon Gregson; J Ties Boerma
Journal:  PLoS Med       Date:  2008-04-08       Impact factor: 11.069

View more
  44 in total

1.  A serial risk score approach to disease classification that accounts for accuracy and cost.

Authors:  Dat Huynh; Oliver Laeyendecker; Ron Brookmeyer
Journal:  Biometrics       Date:  2014-08-25       Impact factor: 2.571

2.  Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.

Authors:  Andrew F Longosz; David Serwadda; Fred Nalugoda; Godfrey Kigozi; Veronica Franco; Ronald H Gray; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

3.  HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.

Authors:  Matthew M Cousins; Jacob Konikoff; Oliver Laeyendecker; Connie Celum; Susan P Buchbinder; George R Seage; Gregory D Kirk; Richard D Moore; Shruti H Mehta; Joseph B Margolick; Joelle Brown; Kenneth H Mayer; Beryl A Koblin; Darrell Wheeler; Jessica E Justman; Sally L Hodder; Thomas C Quinn; Ron Brookmeyer; Susan H Eshleman
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

4.  Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.

Authors:  Karolin Meixenberger; Andrea Hauser; Klaus Jansen; Kaveh Pouran Yousef; Stefan Fiedler; Max von Kleist; Stephen Norley; Sybille Somogyi; Osamah Hamouda; Norbert Bannert; Barbara Bartmeyer; Claudia Kücherer
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

5.  Cross-sectional HIV incidence estimation in an evolving epidemic.

Authors:  Doug Morrison; Oliver Laeyendecker; Ron Brookmeyer
Journal:  Stat Med       Date:  2019-05-21       Impact factor: 2.373

6.  Short Communication: Viral Genetic Linkage Analysis Among Black Men Who Have Sex With Men (HIV Prevention Trials Network 061).

Authors:  Julia Kobe; Octavious Talbot; Iris Chen; Susan H Eshleman; Vanessa Cummings; Darrell Wheeler; Kenneth H Mayer; Victor DeGruttola
Journal:  AIDS Res Hum Retroviruses       Date:  2019-03-18       Impact factor: 2.205

7.  Identifying and characterizing places for the targeted control of heterosexual HIV transmission in urban areas.

Authors:  Sarah Polk; Jonathan M Ellen; Caroline Fichtenberg; Steven Huettner; Meredith Reilly; Jenita Parekh; Jacky M Jennings
Journal:  AIDS Behav       Date:  2014-08

8.  Cross-Sectional HIV Incidence Estimation with Missing Biomarkers.

Authors:  Doug Morrison; Oliver Laeyendecker; Jacob Konikoff; Ron Brookmeyer
Journal:  Stat Commun Infect Dis       Date:  2018-07-31

9.  Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.

Authors:  Reshma Kassanjee; Christopher D Pilcher; Michael P Busch; Gary Murphy; Shelley N Facente; Sheila M Keating; Elaine Mckinney; Kara Marson; Matthew A Price; Jeffrey N Martin; Susan J Little; Frederick M Hecht; Esper G Kallas; Alex Welte
Journal:  AIDS       Date:  2016-09-24       Impact factor: 4.177

10.  Improvements in the continuum of HIV care in an inner-city emergency department.

Authors:  Gabor D Kelen; Yu-Hsiang Hsieh; Richard E Rothman; Eshan U Patel; Oliver B Laeyendecker; Mark A Marzinke; William Clarke; Teresa Parsons; Jordyn L Manucci; Thomas C Quinn
Journal:  AIDS       Date:  2016-01-02       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.